« PreviousNext »Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 264-277, July 2007
Volume 1, Issue 4 , Pages 264-277, July 2007
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis
To access this article, please choose from the options below
This study was funded by Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
PII: S1933-1711(07)00089-7
doi:10.1016/j.jash.2007.04.004
© 2007 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
« PreviousNext »Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 264-277, July 2007
Volume 1, Issue 4 , Pages 264-277, July 2007
